Milestone® Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

Milestone Pharmaceuticals (Nasdaq: MIST) announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York City from September 9-11, 2024. President and CEO Joe Oliveto will engage in a Fireside Chat on September 10th at 2 PM EDT.

The event will be accessible via webcast, available both live and as a replay for approximately 90 days after the presentation. Interested parties can view the webcast in the News & Events section of Milestone's website at www.milestonepharma.com.

This participation provides an opportunity for Milestone Pharmaceuticals to showcase its latest developments and engage with investors in a prominent global investment forum.

MONTREAL and CHARLOTTE, N.C., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Milestone^® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that President and CEO, Joe Oliveto, will participate in the H.C. Wainwright 26^th Annual Global Investment Conference, to take place from September 9-11, 2024, in New York City.

The Fireside Chat will be on September 10^th at 2 PM EDT. The webcast is available to watch both live and replay for approximately 90 days following the presentation in the News & Events section of Milestone's website www.milestonepharma.com.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex and life-altering heart conditions. The Company’s focus on understanding unmet patient needs and improving the patient experience has led us to develop new treatment approaches that provide patients with an active role in self-managing their care. Milestone’s lead investigational product is etripamil, a novel calcium channel blocker nasal spray that is being studied for patients to self-administer without medical supervision to treat symptomatic episodic attacks associated with PSVT and AFib-RVR.

Contact:
Kim Fox, Vice President, Communications,
kfox@milestonepharma.com

Investor Relations
Chris Calabrese,
ccalabrese@lifesciadvisors.com

Kevin Gardner,
kgardner@lifesciadvisors.com

FAQ

When is Milestone Pharmaceuticals (MIST) presenting at the H.C. Wainwright Global Investment Conference?

Milestone Pharmaceuticals (MIST) will present at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, at 2 PM EDT.

Who will represent Milestone Pharmaceuticals (MIST) at the H.C. Wainwright conference?

Joe Oliveto, the President and CEO of Milestone Pharmaceuticals (MIST), will represent the company at the H.C. Wainwright conference.

How can investors watch Milestone Pharmaceuticals' (MIST) presentation at the H.C. Wainwright conference?

Investors can watch Milestone Pharmaceuticals' (MIST) presentation via webcast, available both live and as a replay for about 90 days, in the News & Events section of Milestone's website at www.milestonepharma.com.

What are the dates for the H.C. Wainwright Global Investment Conference featuring Milestone Pharmaceuticals (MIST)?

The H.C. Wainwright 26th Annual Global Investment Conference, featuring Milestone Pharmaceuticals (MIST), will take place from September 9-11, 2024, in New York City.